Orient Europharma Co Ltd (4120) — Free Cash Flow Generation Index
Orient Europharma Co Ltd (4120) has a Free Cash Flow Generation Index of -1.68x as of June 2025. Free cash flow of NT$-55.78 Million represents -2% of operating cash flow (NT$33.25 Million). See how liquid is Orient Europharma Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Free Cash Flow Generation Index (2015–2023)
Historical FCF Generation Index trend for Orient Europharma Co Ltd across 8 annual periods. Explore debt repayment capacity of Orient Europharma Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Orient Europharma Co Ltd (2015–2023)
Year-by-year Free Cash Flow Generation Index for Orient Europharma Co Ltd. For the full company profile including market capitalisation, see 4120 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.56x | NT$-36.03 Million | NT$64.67 Million | NT$100.70 Million | ▲ +97.1% |
| 2021 | -19.19x | NT$-1.49 Billion | NT$77.65 Million | NT$1.56 Billion | ▼ -3227.5% |
| 2020 | 0.61x | NT$373.43 Million | NT$608.55 Million | NT$232.78 Million | ▲ +186.6% |
| 2019 | 0.21x | NT$48.68 Million | NT$227.37 Million | NT$124.98 Million | ▲ +84.2% |
| 2018 | 0.12x | NT$26.88 Million | NT$231.31 Million | NT$201.61 Million | ▼ -80.8% |
| 2017 | 0.61x | NT$364.28 Million | NT$601.08 Million | NT$367.66 Million | ▼ -79.9% |
| 2016 | 3.02x | NT$336.05 Million | NT$111.24 Million | NT$224.81 Million | ▲ +122.7% |
| 2015 | 1.36x | NT$873.51 Million | NT$643.97 Million | NT$229.54 Million | — |